Relationship between transforming growth factor-β1 and type 2 diabetic nephropathy risk in Chinese population
T Zhou, HY Li, H Zhong, Z Zhong - BMC medical genetics, 2018 - Springer
Background Diabetes mellitus (DM) is divided into four different etiological categories: type 1
DM (T1DM), type 2 DM (T2DM), other specific types, and gestational DM. One severe …
DM (T1DM), type 2 DM (T2DM), other specific types, and gestational DM. One severe …
Stanniocalcin-1 reduced intraocular pressure in two models of ocular hypertension
GW Roddy, UR Chowdhury, KJ Monson… - Current eye …, 2021 - Taylor & Francis
ABSTRACT Purpose/Aim: Glaucomatous optic neuropathy (GON) remains the world's
leading cause of irreversible blindness. Treatments including topical medications are …
leading cause of irreversible blindness. Treatments including topical medications are …
Stanniocalcin-1 (STC-1), a downstream effector molecule in latanoprost signaling, acts independent of the FP receptor for intraocular pressure reduction
GW Roddy, TA Rinkoski, KJ Monson, UR Chowdhury… - Plos one, 2020 - journals.plos.org
Prostaglandin F2 alpha (PGF2α) analogues such as latanoprost are common first-line
intraocular pressure (IOP) lowering medications. However, their clinical use is limited in …
intraocular pressure (IOP) lowering medications. However, their clinical use is limited in …
Transgene expression of Stanniocalcin-1 provides sustained intraocular pressure reduction by increasing outflow facility
GW Roddy, U Roy Chowdhury, KJ Anderson… - PloS one, 2022 - journals.plos.org
Glaucoma is the leading cause of irreversible blindness worldwide. Therapies for glaucoma
are directed toward reducing intraocular pressure (IOP), the leading risk factor and only …
are directed toward reducing intraocular pressure (IOP), the leading risk factor and only …
Switching within glaucoma medication class
SK Law - Current Opinion in Ophthalmology, 2009 - journals.lww.com
In addition to keeping up-to-date with the efficacy and safety profiles of drugs within each
glaucoma medication class, clinicians should familiarize themselves with the different …
glaucoma medication class, clinicians should familiarize themselves with the different …
[PDF][PDF] Association of ocular biometry and PTGFR gene in primary angle closure
KR Maharajah, NY Ling, N Zahary… - International Medical …, 2015 - researchgate.net
Background: Ocular biometric parameter and its role in the pathogenesis of primary angle
closure (PAC) have been well documented. The occurrence of an acute presentation of …
closure (PAC) have been well documented. The occurrence of an acute presentation of …
[图书][B] Menelusuri Rahsia Penyakit Glaukoma dalam Etnik Melayu (Penerbit USM)
LSA Tajudin - 2020 - books.google.com
Glaukoma merupakan penyebab utama kebutaan yang tidak dapat dipulihkan. Pemahaman
tentang penyakit ini adalah penting dalam pencegahan kebutaan ke arah kebutaan sifar …
tentang penyakit ini adalah penting dalam pencegahan kebutaan ke arah kebutaan sifar …
Genetics of Ocular Diseases in Malaysia
AT Liza-Sharmini, TA Kamalden - Advances in Vision Research, Volume II …, 2019 - Springer
Understanding the role of genetics in clinical practice has evolved drastically in Malaysia.
However, the understanding of genetics in ocular diseases is still at the infancy. In this …
However, the understanding of genetics in ocular diseases is still at the infancy. In this …
Glokom ilaçlarının grup içi değişimi
SK Law - Current Opinion in Ophthalmology, 2009 - turkiyeklinikleri.com
Her bir glokom ilaç grubunun etkinlik ve güvenilirlik profili bilgilerini güncellemenin yanında
klinisyenler etkin glokom tedavisi yapabilmek için farklı ilaç formülizasyonlarının …
klinisyenler etkin glokom tedavisi yapabilmek için farklı ilaç formülizasyonlarının …